Application 207366
- Type
- ANDA
- Sponsor
- NAVINTA LLC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | RIBAVIRIN | RIBAVIRIN | FOR SOLUTION;INHALATION | 6GM/VIAL | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 68382-395 | RIBAVIRIN | ribavirin | Zydus Pharmaceuticals USA Inc. | ANDA | Current |
| 68382-395 | RIBAVIRIN | ribavirin | Zydus Pharmaceuticals USA Inc. | ANDA | Current |
| 68382-395 | RIBAVIRIN | ribavirin | Zydus Pharmaceuticals USA Inc. | ANDA | Current |
| 68475-003 | RIBAVIRIN | ribavirin | Navinta LLC | ANDA | Current |
| 68475-003 | RIBAVIRIN | ribavirin | Navinta LLC | ANDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 45576 | ORIG | 2016-10-14 |